Journals
Publish with us
Publishing partnerships
About us
Blog
Gastroenterology Research and Practice
Journal overview
For authors
For reviewers
For editors
Table of Contents
Special Issues
Gastroenterology Research and Practice
/
2013
/
Article
/
Fig 1
/
Review Article
PP2A-Mediated Anticancer Therapy
Figure 1
Bortezomib and erlotinib restore PP2A activity by targeting CIP2A. Bortezomib and erlotinib downregulate CIP2A which leads to up-regulation of PP2A activity and therefore inhibiting cell transformation by inactivating Akt.
